Tumor infiltrating lymphocytes (TIL) together with CD8+ T cells promote favorable prognosis in ovarian cancer [26], however, lymphocytopenia represent a state of decline in the cell-mediated immune which may limit tumor control following surgery and chemotherapy [27,28]. The gene discussed is CD8A; the disease is neoplasm.